Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Currency in USD	2025
Operating Income	N/A
Income Before Tax	32.58 Billion
Income Tax Expense	5.78 Billion
Net Income	26.80 Billion
Eps	11.13
Epsdiluted	11.03
Weighted Average Shs Out	2.41 Billion
Weighted Average Shs Out Dil	2.43 Billion
Research And Development Expenses	109.00 Million
Selling General And Administrative Expenses	23.68 Billion
Depreciation And Amortization	7.50 Billion
Interest Expense	971.00 Million
Gross Profit	63.94 Billion
Ebitda	N/A

Johnson & Johnson Annual Reports (10-K)